Graft Versus Host Disease (GvHD) Latest Advances

Itacitinib plus calcineurin inhibitor-based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 results.

Journal: Research square

Published: June 22, 2026

Allogeneic CAR-T cell therapies: Overcoming clinical challenges and therapeutic potential against tumors.

Journal: Journal of biomedical research

Published: June 21, 2026

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Journal: Current opinion in hematology

Published: June 19, 2026

Development of a Knowledge Map for Managing Symptoms of Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Journal: Computers, informatics, nursing : CIN

Published: June 18, 2026

Guillain-Barré syndrome following allogeneic hematopoietic stem cell transplantation in a pediatric patient: a case report and literature review

Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics

Published: June 17, 2026

Immune dynamics and predictive factors for chronic graft versus host disease following haploidentical hematopoietic stem cell transplantation in children

Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics

Published: June 17, 2026

Immunological Interplay at the Ocular Surface of Stevens-Johnson Syndrome, Ocular Cicatricial Pemphigoid, and Ocular Graft Versus Host Disease.

Journal: Investigative ophthalmology & visual science

Published: June 15, 2026

Pre-transplant Clostridioides difficile infection predicts subsequent gastrointestinal GVHD and non-relapse mortality after allogeneic hematopoietic stem cell transplantation.

Journal: Cell transplantation

Published: June 13, 2026

Cytomegalovirus prophylaxis using low-dose and ultra-low-dose valganciclovir for patients who have undergone allogeneic hematopoietic stem cell transplantation: A retrospective study.

Journal: The Journal of international medical research

Published: June 13, 2026

Translation and validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in Denmark.

Journal: Danish medical journal

Published: June 11, 2026

T cell-macrophage crosstalk in GVHD and cancer immunotherapy.

Journal: Cell investigation

Published: June 11, 2026

Chronic graft-versus-host disease.

Journal: Nature reviews. Disease primers

Published: June 11, 2026

Graft Versus Host Disease (GvHD) Latest Advances

Find the Latest Research About Graft Versus Host Disease (GvHD)

Itacitinib plus calcineurin inhibitor-based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 results.

Itacitinib plus calcineurin inhibitor-based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 results.

Allogeneic CAR-T cell therapies: Overcoming clinical challenges and therapeutic potential against tumors.

Allogeneic CAR-T cell therapies: Overcoming clinical challenges and therapeutic potential against tumors.

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Development of a Knowledge Map for Managing Symptoms of Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Development of a Knowledge Map for Managing Symptoms of Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Guillain-Barré syndrome following allogeneic hematopoietic stem cell transplantation in a pediatric patient: a case report and literature review

Guillain-Barré syndrome following allogeneic hematopoietic stem cell transplantation in a pediatric patient: a case report and literature review

Immune dynamics and predictive factors for chronic graft versus host disease following haploidentical hematopoietic stem cell transplantation in children

Immune dynamics and predictive factors for chronic graft versus host disease following haploidentical hematopoietic stem cell transplantation in children

Immunological Interplay at the Ocular Surface of Stevens-Johnson Syndrome, Ocular Cicatricial Pemphigoid, and Ocular Graft Versus Host Disease.

Immunological Interplay at the Ocular Surface of Stevens-Johnson Syndrome, Ocular Cicatricial Pemphigoid, and Ocular Graft Versus Host Disease.

Pre-transplant Clostridioides difficile infection predicts subsequent gastrointestinal GVHD and non-relapse mortality after allogeneic hematopoietic stem cell transplantation.

Pre-transplant Clostridioides difficile infection predicts subsequent gastrointestinal GVHD and non-relapse mortality after allogeneic hematopoietic stem cell transplantation.

Cytomegalovirus prophylaxis using low-dose and ultra-low-dose valganciclovir for patients who have undergone allogeneic hematopoietic stem cell transplantation: A retrospective study.

Cytomegalovirus prophylaxis using low-dose and ultra-low-dose valganciclovir for patients who have undergone allogeneic hematopoietic stem cell transplantation: A retrospective study.

Translation and validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in Denmark.

Translation and validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in Denmark.

T cell-macrophage crosstalk in GVHD and cancer immunotherapy.

T cell-macrophage crosstalk in GVHD and cancer immunotherapy.

Chronic graft-versus-host disease.

Chronic graft-versus-host disease.